- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 231/54 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 231/54
Total number of patents in this class: 318
10-year publication summary
|
25
|
25
|
23
|
24
|
36
|
26
|
13
|
19
|
18
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Arena Pharmaceuticals, Inc. | 381 |
25 |
| Gilead Sciences, Inc. | 1879 |
13 |
| Reata Pharmaceuticals, Inc. | 127 |
12 |
| Janssen Pharmaceutica N.V. | 3839 |
10 |
| Novartis AG | 11238 |
8 |
| Bristol-myers Squibb Company | 5080 |
7 |
| Taro Pharmaceuticals Inc. | 42 |
7 |
| F. Hoffmann-La Roche AG | 7958 |
6 |
| Bayer Pharma AG | 1096 |
6 |
| Array BioPharma Inc. | 551 |
6 |
| Bioardis, LLC | 37 |
6 |
| Abbvie Inc. | 1808 |
5 |
| Merck Sharp & Dohme LLC | 3689 |
5 |
| Boehringer Ingelheim International GmbH | 4629 |
4 |
| Merck Patent GmbH | 5909 |
4 |
| Duke University | 2872 |
4 |
| Esanex, Inc. | 8 |
4 |
| Glaxo Group Limited | 4496 |
3 |
| AstraZeneca AB | 3042 |
3 |
| Pfizer Inc. | 3322 |
3 |
| Other owners | 177 |